True North
True North is an India-focused private-equity and private-credit manager that began as India Value Fund Advisors. Its PE strategy partners with entrepreneurs in consumer, financial services, healthcare and technology, while its credit business provides bespoke financing to middle-market companies.
At a glance
- Founded
- 1999
- Footprint
- Mumbai
- Stage
- Control mid-market
Research profile
Read the manager in sequence.
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
True North uses a control mid-market approach across Health, fin services, consumer.
Current evidence
True North’s March 2026 sustainability disclosures show Fund VII fundraising in progress as of March 31, 2025 with two investments made from capital raised, while its current partner-company page identifies a live private-equity portfolio including Accion Labs, Atria Convergence Technologies, Anthem Biosciences, Biocon Biologics, Cloudnine, HomeFirst, Nivara Home Finance, Niva Bupa, NSE, QuEST Global, SeedWorks and Vistaar Finance.
Strategy
Control mid-market
Sector focus
Health, fin services, consumer
Current signal
True North’s March 2026 sustainability disclosures show Fund VII fundraising in progress as of March 31, 2025 with two investments made from capital raised, while its current partner-company page identifies a live private-equity portfolio including Accion Labs, Atria Convergence Technologies, Anthem Biosciences, Biocon Biologics, Cloudnine, HomeFirst, Nivara Home Finance, Niva Bupa, NSE, QuEST Global, SeedWorks and Vistaar Finance.
Next step
Need this manager reviewed against your mandate?
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.